Company intelligence / Profile preview
Bayer
Leverkusen, North Rhine-Westphalia, Germanybayer.com ↗
- Ownership
- Public · BAYN
- Employees
- ~99000
- Development stage
- Commercial
01
Overview
Bayer AG is a global life sciences company with leading positions in pharmaceuticals, consumer health products, crop science/agrochemicals, and animal health. Its pharmaceutical division focuses on oncology, cardiology/nephrology/metabolic diseases, women’s health/menopause management, rare diseases/neurology including Parkinson’s disease cell/gene therapies. In recent years it has launched several blockbuster drugs such as NUBEQA® for prostate cancer while advancing a broad R&D pipeline across small molecules to advanced genetic medicines.[7][8]
- Therapeutic areas
- CardiovascularNephrologyOphthalmologyImmunologyWomen's HealthOncologyRare DiseasesNeurology
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)Protein therapeuticsCell therapyGene therapy (including rAAV gene therapies)Radionuclide therapy[10]
- Industry
- Pharma
02
Drug pipeline
346 assets345 more assets in the full pipeline.
Request access →03
Partnerships
Recent partnerships with Merck & Co., CuraGen Corporation ($1.64 billion alliance), academic collaborations globally.[7]ongoing co-development/licensing deals especially in cardiovascular/metabolic space.
04
Financials
- Market cap
- $14.2B
- Total revenue
- $4.5B
- Enterprise value
- $26.6B
Beyond the preview
Go deeper on Bayer.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bayer.